Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs

Co-infections with human immunodeficiency virus type 1 (HIV-1) and human pegivirus (HPgV) are common in hepatitis C virus (HCV)-infected individuals. However, analysis on the evolutionary dynamics and transmission network profiles of these viruses among individuals with multiple infections remains l...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Ng, K.T., Takebe, Y., Chook, J.B., Chow, W.Z., Chan, Kok Gan, Al-Darraji, H.A., Kamarulzaman, Adeeba, Tee, Kok Keng
Fformat: Erthygl
Cyhoeddwyd: Nature Publishing Group 2015
Pynciau:
_version_ 1825721319366328320
author Ng, K.T.
Takebe, Y.
Chook, J.B.
Chow, W.Z.
Chan, Kok Gan
Al-Darraji, H.A.
Kamarulzaman, Adeeba
Tee, Kok Keng
author_facet Ng, K.T.
Takebe, Y.
Chook, J.B.
Chow, W.Z.
Chan, Kok Gan
Al-Darraji, H.A.
Kamarulzaman, Adeeba
Tee, Kok Keng
author_sort Ng, K.T.
collection UM
description Co-infections with human immunodeficiency virus type 1 (HIV-1) and human pegivirus (HPgV) are common in hepatitis C virus (HCV)-infected individuals. However, analysis on the evolutionary dynamics and transmission network profiles of these viruses among individuals with multiple infections remains limited. A total of 228 injecting drug users (IDUs), either HCV-and/or HIV-1-infected, were recruited in Kuala Lumpur, Malaysia. HCV, HIV-1 and HPgV genes were sequenced, with epidemic growth rates assessed by the Bayesian coalescent method. Based on the sequence data, mono-, dual-and triple-infection were detected in 38.8%, 40.6% and 20.6% of the subjects, respectively. Fifteen transmission networks involving HCV (subtype 1a, 1b, 3a and 3b), HIV-1 (CRF33-01B) and HPgV (genotype 2) were identified and characterized. Genealogical estimates indicated that the predominant HCV, HIV-1 and HPgV genotypes were introduced into the IDUs population through multiple sub-epidemics that emerged as early as 1950s (HCV), 1980s (HIV-1) and 1990s (HPgV). By determining the difference in divergence times between viral lineages (δtMRCA), we also showed that the frequency of viral co-transmission is low among these IDUs. Despite increased access to therapy and other harm reduction interventions, the continuous emergence and coexistence of new transmission networks suggest persistent multiple viral transmissions among IDUs.
first_indexed 2024-03-06T05:48:36Z
format Article
id um.eprints-19540
institution Universiti Malaya
last_indexed 2024-03-06T05:48:36Z
publishDate 2015
publisher Nature Publishing Group
record_format dspace
spelling um.eprints-195402019-12-23T05:56:17Z http://eprints.um.edu.my/19540/ Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs Ng, K.T. Takebe, Y. Chook, J.B. Chow, W.Z. Chan, Kok Gan Al-Darraji, H.A. Kamarulzaman, Adeeba Tee, Kok Keng R Medicine Co-infections with human immunodeficiency virus type 1 (HIV-1) and human pegivirus (HPgV) are common in hepatitis C virus (HCV)-infected individuals. However, analysis on the evolutionary dynamics and transmission network profiles of these viruses among individuals with multiple infections remains limited. A total of 228 injecting drug users (IDUs), either HCV-and/or HIV-1-infected, were recruited in Kuala Lumpur, Malaysia. HCV, HIV-1 and HPgV genes were sequenced, with epidemic growth rates assessed by the Bayesian coalescent method. Based on the sequence data, mono-, dual-and triple-infection were detected in 38.8%, 40.6% and 20.6% of the subjects, respectively. Fifteen transmission networks involving HCV (subtype 1a, 1b, 3a and 3b), HIV-1 (CRF33-01B) and HPgV (genotype 2) were identified and characterized. Genealogical estimates indicated that the predominant HCV, HIV-1 and HPgV genotypes were introduced into the IDUs population through multiple sub-epidemics that emerged as early as 1950s (HCV), 1980s (HIV-1) and 1990s (HPgV). By determining the difference in divergence times between viral lineages (δtMRCA), we also showed that the frequency of viral co-transmission is low among these IDUs. Despite increased access to therapy and other harm reduction interventions, the continuous emergence and coexistence of new transmission networks suggest persistent multiple viral transmissions among IDUs. Nature Publishing Group 2015 Article PeerReviewed Ng, K.T. and Takebe, Y. and Chook, J.B. and Chow, W.Z. and Chan, Kok Gan and Al-Darraji, H.A. and Kamarulzaman, Adeeba and Tee, Kok Keng (2015) Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Scientific Reports, 5 (1). p. 15198. ISSN 2045-2322, DOI https://doi.org/10.1038/srep15198 <https://doi.org/10.1038/srep15198>. http://dx.doi.org/10.1038/srep15198 doi:10.1038/srep15198
spellingShingle R Medicine
Ng, K.T.
Takebe, Y.
Chook, J.B.
Chow, W.Z.
Chan, Kok Gan
Al-Darraji, H.A.
Kamarulzaman, Adeeba
Tee, Kok Keng
Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title_full Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title_fullStr Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title_full_unstemmed Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title_short Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
title_sort co infections and transmission networks of hcv hiv 1 and hpgv among people who inject drugs
topic R Medicine
work_keys_str_mv AT ngkt coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT takebey coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT chookjb coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT chowwz coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT chankokgan coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT aldarrajiha coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT kamarulzamanadeeba coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs
AT teekokkeng coinfectionsandtransmissionnetworksofhcvhiv1andhpgvamongpeoplewhoinjectdrugs